| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 844.21 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Progression through dissemination to tumor-surrounding tissues and metastasis development is a hallmark of cancer that requires continuous cell-to-cell interactions and tissue remodeling. In fact, metastization can be regarded as a tissue disease orchestrated by cancer cells, leading to neoplastic colonization of new organs. Collagen is a major component of the extracellular matrix (ECM), and increasing evidence suggests that it has an important role in cancer progression and metastasis. Desmoplasia and collagen biomarkers have been associated with relapse and death in cancer patients. Despite the increasing interest in ECM and in the desmoplastic process in tumor microenvironment as prognostic factors and therapeutic targets in cancer, further research is required for a better understanding of these aspects of cancer biology. In this review, published evidence correlating collagen with cancer prognosis is retrieved and analyzed, and the role of collagen and its fragments in cancer pathophysiology is discussed.
Description
© Springer Science+Business Media, LLC, part of Springer Nature 2020
Keywords
Biologic functions Cancer Collagen Collagen fragments Desmoplasia Prognostic tools
Pedagogical Context
Citation
Cancer Metastasis Rev. 2020 Sep;39(3):603-623
Publisher
Springer Nature